Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Shaw SM et al. - Both atorvastatin and ezetimibe may have selective immunomodulatory properties independent of their mechanisms of LDL lowering, given that both drugs affect CD4 T helper cells but have no effect on CD8 cytotoxic lymphocytes in vitro. Although speculative, both of these agents could potentially offer benefits to the transplant patient by modulating important components of the adaptive immune system.

Today in Clinical Pharmacology...keeping you current

Severe atopic dermatitis treated with everolimus
Journal of Dermatological Treatment , 12/07/09

Benefits of budesonide or nedocromil for mild to moderate asthma in children were not sustained after discontinuation
Evidence-Based Medicine, 12/07/09

Currently approved prophylactic HPV vaccines
Expert Review of Vaccines, 12/07/09

Today in Surgery/Transplantation...keeping you current

Measuring vs estimating glomerular filtration rate in kidney transplantation
Transplantation Reviews, 12/07/09

Paired kidney donations to expand the living donor pool
Journal of Nephrology, 12/07/09

HLA-DR expression and differential trafficking of monocyte subsets following low to intermediate risk surgery
Anaesthesia, 12/07/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address